23/46
  • Pages
  • Editions
01 Cover
02 Welcome Letter / Sections
03 Section 1: Introduction to India's Life Sciences Sector
04 Pharmacy of the Post-Pandemic World
05 IDMA Interview
06 Pharmexcil Interview
07 FDCA Gujarat Interview
08 Expert Article: Indian Pharma 2023 Outlook
09 Section 2: The World's Pharmacy
10 Access, Affordability and Quality
11 Asence Pharma Private Limited Interview
12 Mercury Laboratories Interview
13 BDR Pharmaceuticals Interview
14 Symbio Generrics Interview
15 India's Take on Innovation
16 Biofoundry Technologies Interview
17 Meteoric Biopharmaceuticals Interview
18 ZIM Laboratories Interview
19 Saga Life Sciences Ltd Interview
20 India and the World
21 Executive Insights: Competition with China
22 Merck Life Science Interview
23 Azelis Interview
24 Ferring Pharmaceuticals Interview
25 Alembic Pharmaceuticals Interview
26 Section 3: Sub-Sectors on the Rise
27 Nutraceuticals
28 Generex Pharmassist Interview
29 Millennium Herbal Care Interview
30 Vasu Healthcare Interview
31 Digital Health
32 MedPrime Technologies Interview
33 Medical devices
34 Premier Medical Corporation Interview
35 Agappe Diagnostics Interview
36 Section 4: Services and Support
37 Contract Services
38 Lambda Therapeutic Research Interview
39 Veeda Clinical Research Interview
40 Bioneeds Interview
41 Piramal Pharma Limited Interview
42 Sai Life Sciences Interview
43 ACG Interview
44 Akums Interview
45 Article & Interview Directory
46 Credits

Aparna Khurana, Managing Director - India,

AZELIS

"Azelis has focused on ensuring the growth of its business in India over the past few years through strategic acquisitions and key mandate wins, all while actively developing its portfolio of specialty chemicals and food ingredients in India."

Can you share with our readers the history of Azelis’ presence in India?

Azelis India was established in 2012 and is currently active in nine market segments across the life sciences and industrial chemicals industry, including pharma, food, chemicals, CASE, agri and personal care to name a few.

With offices and warehouses in Mumbai and Delhi NCR, the Azelis India team of over 150 employees include some of the best industry professionals in the country, as well as skilled technical experts for the Pharma, CASE, Food, Personal Care and Agri markets, who manage dedicated laboratories for each of those markets.

Azelis has focused on ensuring the growth of its business in India over the past few years through strategic acquisitions and key mandate wins, all while actively developing its portfolio of specialty chemicals and food ingredients in India.

How does the company leverage its footprint in India to serve local markets as well as assist principals in expanding their business to India?

By building strong relationships with key local and global players in the industry, Azelis India is able to offer a comprehensive range of chemicals and ingredients from first-class manufacturers that allow us to support customers with their formulation challenges.

Our strong partnerships with our principals help them reduce complexity by acting as an extension of their sales organization and bringing their portfolio of products to new audiences in the local market, allowing us to not only serve the local markets but also to offer our principals a route to market in the Indian economy.

What types of clients does Azelis typically take on within India’s life sciences sector?

Our customers range from small medium enterprises to multi-national corporations.

To further support our customers, we introduced our Customer Portals for various market segments to provide customers with information on trends, formulation inspiration, product documentation, and 24/7 access to our technical expertise. By leveraging our digital solutions, we will also be able to accurately capture additional information, allowing for further insights into ingredient recommendations and formulation requirements for both our technical experts and our principals.

Azelis announced in November 2022 the inauguration of its first pharmaceuticals and healthcare laboratory in India. How will this lab enable your company to better service the Indian pharmaceutical industry?

Thanks to the lab, our technical expertise and innovation resources will be accessible to a wider audience within the pharma industry. The lab’s capabilities ensure we will continue to develop innovative solutions that are market-leading and incorporate leading trends, allowing us to deliver on our brand promise, ‘Innovation through formulation’.

We will make certain that our solutions leverage market trends such as well-being and health, as we also strengthen our lateral value chain with nutraceuticals.

Can you provide an overview of Azelis’ Pharma portfolio?

Constant development, changing regulations and evolving healthcare demands are all challenges our partners in the pharmaceutical market face day in day out. We are a one-stop shop for all our customer’s needs and offer them ingredients, cleaning solutions, packaging material and testing equipment. We offer various products including functional pharmaceutical excipients which helps in taste masking, moisture protection, film coating, tablet coating, drug delivery, anti-cracking, binding for solid and oral dosage forms. We also offer Halal, Cosher, RSPO certified products.

How does Azelis approach the topic of sustainability?

Sustainability is ingrained in everything we do, which is why we are actively reviewing our portfolio to identify sustainable products, which can then be used to develop sustainable formulations, and allow us to suggest sustainable alternatives to our customers. This is especially important as consumers are increasingly more conscious about their impact on the planet and desire a more sustainable lifestyle.

We aim to advance the sustainability agendas of our stakeholders by leveraging our lateral value chain and technical expertise to develop new or alternative sustainable formulations, cascading sustainable materials into the supply chain and innovating for a better tomorrow.

Azelis is proud to have received the EcoVadis Platinum rating, the highest ESG ranking in our industry from Sustainalytics, and be part of Together for Sustainability, all of which reflects our commitments and achievements towards building a sustainable future.

Next:

Interview: Ferring Pharmaceuticals